Agnès Conjard‐Duplany

Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy

Valérie Risson, Laetitia Mazelin, Mila Roceri et al. · The Journal of Cell Biology · 2009 · 368 citations · Full text

Muscle Function, Metabolic Remodeling, Cellular Physiology +21

Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to Schizophrenia

Inna Gaisler‐Salomon, Gretchen M. Miller, Nao Chuhma et al. · Neuropsychopharmacology · 2009 · 87 citations · Full text

Neuropsychology, Psychoactive Drug, Psychiatry +11

Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function

Klaas Romanino, Laetitia Mazelin, Verena Albert et al. · Proceedings of the National Academy of Sciences · 2011 · 43 citations

Mitophagy, Inactivated Mtorc1 Signaling, Mitochondrial Dysfunction +20

Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole‐body homeostasis

Qing Zhang, Agnès Conjard‐Duplany, Vincent Moncollin et al. · Journal of Cachexia Sarcopenia and Muscle · 2018 · 28 citations · Full text

Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy

Valérie Risson, Laetitia Mazelin, Mila Roceri et al. · The Journal of Experimental Medicine · 2009 · 17 citations

Mitochondrial Myopathy, Muscle Pathology, Muscle Function +12